The Senior Director leads external communications for Lilly's on-market cardiometabolic medicines — currently Mounjaro (tirzepatide for type 2 diabetes), Zepbound (tirzepatide for obesity), and Foundayo (orforglipron for obesity) — as well as new indications and label expansions as they are approved. This role owns the consumer obesity communications strategy, which is a defining capability of the CMH Communications team, and leads global communications for all approved products, including coordination with international affiliates across 40+ markets. This is a high-visibility, high-velocity role that requires both strategic vision and the ability to move fast. The Senior Director must be as comfortable shaping a long-term consumer narrative as they are managing an emerging media issue — and must actively contribute across the broader CMH Communications team as priorities shift.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director